Releases
AMPE
0.9200
+12.20%
0.1000
  • All
  • Financials
  • Insiders
More
Webull provides the latest Ampio Pharma (AMPE) stock and general news. This information may help you make smarter investment decisions.
About AMPE
Ampio Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on the preclinical development of AR-300, and is conducting studies to evaluate the efficacy of AR-300 in osteoarthritis-related pain. The Company is primarily targeting the clinical development of AR-300 for the treatment of osteoarthritis of the knee (OAK). AR-300 is a small-molecule formulation that has demonstrated anti-inflammatory properties in vitro and protection of cartilage in preclinical rat meniscal tear studies.